nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Transaminases increased—Lovastatin—atherosclerosis	0.0353	0.0353	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Ezetimibe—atherosclerosis	0.0346	0.0346	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Simvastatin—atherosclerosis	0.033	0.033	CcSEcCtD
Ceftaroline fosamil—Transaminases increased—Pravastatin—atherosclerosis	0.0298	0.0298	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Rosuvastatin—atherosclerosis	0.0134	0.0134	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Lovastatin—atherosclerosis	0.0133	0.0133	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Ezetimibe—atherosclerosis	0.0131	0.0131	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Rosuvastatin—atherosclerosis	0.0127	0.0127	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Simvastatin—atherosclerosis	0.0125	0.0125	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Ezetimibe—atherosclerosis	0.0118	0.0118	CcSEcCtD
Ceftaroline fosamil—Infestation—Ezetimibe—atherosclerosis	0.0118	0.0118	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Pravastatin—atherosclerosis	0.0113	0.0113	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.0111	0.0111	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Lovastatin—atherosclerosis	0.0108	0.0108	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Ezetimibe—atherosclerosis	0.0106	0.0106	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Simvastatin—atherosclerosis	0.0101	0.0101	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Ezetimibe—atherosclerosis	0.00958	0.00958	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Ezetimibe—atherosclerosis	0.00954	0.00954	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Niacin—atherosclerosis	0.00925	0.00925	CcSEcCtD
Ceftaroline fosamil—Erythema—Ezetimibe—atherosclerosis	0.0092	0.0092	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Ezetimibe—atherosclerosis	0.0092	0.0092	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Pravastatin—atherosclerosis	0.00911	0.00911	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00885	0.00885	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00884	0.00884	CcSEcCtD
Ceftaroline fosamil—Erythema—Simvastatin—atherosclerosis	0.00877	0.00877	CcSEcCtD
Ceftaroline fosamil—Anaemia—Ezetimibe—atherosclerosis	0.0085	0.0085	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Niacin—atherosclerosis	0.00839	0.00839	CcSEcCtD
Ceftaroline fosamil—Palpitations—Ezetimibe—atherosclerosis	0.00813	0.00813	CcSEcCtD
Ceftaroline fosamil—Anaemia—Simvastatin—atherosclerosis	0.00811	0.00811	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Niacin—atherosclerosis	0.00805	0.00805	CcSEcCtD
Ceftaroline fosamil—Erythema—Niacin—atherosclerosis	0.00805	0.00805	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00778	0.00778	CcSEcCtD
Ceftaroline fosamil—Pain—Rosuvastatin—atherosclerosis	0.00772	0.00772	CcSEcCtD
Ceftaroline fosamil—Constipation—Rosuvastatin—atherosclerosis	0.00772	0.00772	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Lovastatin—atherosclerosis	0.00765	0.00765	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00751	0.00751	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Lovastatin—atherosclerosis	0.00749	0.00749	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00738	0.00738	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Ezetimibe—atherosclerosis	0.00736	0.00736	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00735	0.00735	CcSEcCtD
Ceftaroline fosamil—Anaemia—Pravastatin—atherosclerosis	0.00733	0.00733	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Ezetimibe—atherosclerosis	0.00729	0.00729	CcSEcCtD
Ceftaroline fosamil—Urticaria—Rosuvastatin—atherosclerosis	0.00717	0.00717	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Simvastatin—atherosclerosis	0.00716	0.00716	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Rosuvastatin—atherosclerosis	0.00714	0.00714	CcSEcCtD
Ceftaroline fosamil—Palpitations—Niacin—atherosclerosis	0.00712	0.00712	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Simvastatin—atherosclerosis	0.00701	0.00701	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00681	0.00681	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00665	0.00665	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Niacin—atherosclerosis	0.00657	0.00657	CcSEcCtD
Ceftaroline fosamil—Pain—Lovastatin—atherosclerosis	0.00654	0.00654	CcSEcCtD
Ceftaroline fosamil—Constipation—Lovastatin—atherosclerosis	0.00654	0.00654	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00648	0.00648	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Pravastatin—atherosclerosis	0.00647	0.00647	CcSEcCtD
Ceftaroline fosamil—Pain—Ezetimibe—atherosclerosis	0.00642	0.00642	CcSEcCtD
Ceftaroline fosamil—Constipation—Ezetimibe—atherosclerosis	0.00642	0.00642	CcSEcCtD
Ceftaroline fosamil—Pruritus—Rosuvastatin—atherosclerosis	0.00639	0.00639	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Niacin—atherosclerosis	0.00638	0.00638	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Pravastatin—atherosclerosis	0.00634	0.00634	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00626	0.00626	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00618	0.00618	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Rosuvastatin—atherosclerosis	0.00618	0.00618	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00614	0.00614	CcSEcCtD
Ceftaroline fosamil—Pain—Simvastatin—atherosclerosis	0.00612	0.00612	CcSEcCtD
Ceftaroline fosamil—Constipation—Simvastatin—atherosclerosis	0.00612	0.00612	CcSEcCtD
Ceftaroline fosamil—Urticaria—Lovastatin—atherosclerosis	0.00608	0.00608	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Lovastatin—atherosclerosis	0.00605	0.00605	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Lovastatin—atherosclerosis	0.00605	0.00605	CcSEcCtD
Ceftaroline fosamil—Dizziness—Rosuvastatin—atherosclerosis	0.00597	0.00597	CcSEcCtD
Ceftaroline fosamil—Urticaria—Ezetimibe—atherosclerosis	0.00596	0.00596	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Ezetimibe—atherosclerosis	0.00593	0.00593	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Ezetimibe—atherosclerosis	0.00593	0.00593	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00585	0.00585	CcSEcCtD
Ceftaroline fosamil—Rash—Rosuvastatin—atherosclerosis	0.00569	0.00569	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Rosuvastatin—atherosclerosis	0.00569	0.00569	CcSEcCtD
Ceftaroline fosamil—Urticaria—Simvastatin—atherosclerosis	0.00569	0.00569	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Niacin—atherosclerosis	0.00567	0.00567	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Simvastatin—atherosclerosis	0.00566	0.00566	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Simvastatin—atherosclerosis	0.00566	0.00566	CcSEcCtD
Ceftaroline fosamil—Headache—Rosuvastatin—atherosclerosis	0.00566	0.00566	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Lovastatin—atherosclerosis	0.00564	0.00564	CcSEcCtD
Ceftaroline fosamil—Pain—Niacin—atherosclerosis	0.00562	0.00562	CcSEcCtD
Ceftaroline fosamil—Constipation—Pravastatin—atherosclerosis	0.00553	0.00553	CcSEcCtD
Ceftaroline fosamil—Pain—Pravastatin—atherosclerosis	0.00553	0.00553	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Ezetimibe—atherosclerosis	0.00553	0.00553	CcSEcCtD
Ceftaroline fosamil—Pruritus—Lovastatin—atherosclerosis	0.00541	0.00541	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Niacin—atherosclerosis	0.00537	0.00537	CcSEcCtD
Ceftaroline fosamil—Nausea—Rosuvastatin—atherosclerosis	0.00536	0.00536	CcSEcCtD
Ceftaroline fosamil—Pruritus—Ezetimibe—atherosclerosis	0.00531	0.00531	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00529	0.00529	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Simvastatin—atherosclerosis	0.00527	0.00527	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Lovastatin—atherosclerosis	0.00524	0.00524	CcSEcCtD
Ceftaroline fosamil—Urticaria—Niacin—atherosclerosis	0.00522	0.00522	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Niacin—atherosclerosis	0.0052	0.0052	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Niacin—atherosclerosis	0.0052	0.0052	CcSEcCtD
Ceftaroline fosamil—Urticaria—Pravastatin—atherosclerosis	0.00514	0.00514	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Ezetimibe—atherosclerosis	0.00514	0.00514	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Pravastatin—atherosclerosis	0.00512	0.00512	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Pravastatin—atherosclerosis	0.00512	0.00512	CcSEcCtD
Ceftaroline fosamil—Pruritus—Simvastatin—atherosclerosis	0.00506	0.00506	CcSEcCtD
Ceftaroline fosamil—Dizziness—Lovastatin—atherosclerosis	0.00506	0.00506	CcSEcCtD
Ceftaroline fosamil—Dizziness—Ezetimibe—atherosclerosis	0.00496	0.00496	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Simvastatin—atherosclerosis	0.0049	0.0049	CcSEcCtD
Ceftaroline fosamil—Vomiting—Lovastatin—atherosclerosis	0.00487	0.00487	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Niacin—atherosclerosis	0.00484	0.00484	CcSEcCtD
Ceftaroline fosamil—Rash—Lovastatin—atherosclerosis	0.00482	0.00482	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Lovastatin—atherosclerosis	0.00482	0.00482	CcSEcCtD
Ceftaroline fosamil—Headache—Lovastatin—atherosclerosis	0.00479	0.00479	CcSEcCtD
Ceftaroline fosamil—Vomiting—Ezetimibe—atherosclerosis	0.00477	0.00477	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Pravastatin—atherosclerosis	0.00477	0.00477	CcSEcCtD
Ceftaroline fosamil—Dizziness—Simvastatin—atherosclerosis	0.00473	0.00473	CcSEcCtD
Ceftaroline fosamil—Rash—Ezetimibe—atherosclerosis	0.00473	0.00473	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Ezetimibe—atherosclerosis	0.00473	0.00473	CcSEcCtD
Ceftaroline fosamil—Headache—Ezetimibe—atherosclerosis	0.0047	0.0047	CcSEcCtD
Ceftaroline fosamil—Pruritus—Niacin—atherosclerosis	0.00465	0.00465	CcSEcCtD
Ceftaroline fosamil—Pruritus—Pravastatin—atherosclerosis	0.00458	0.00458	CcSEcCtD
Ceftaroline fosamil—Vomiting—Simvastatin—atherosclerosis	0.00455	0.00455	CcSEcCtD
Ceftaroline fosamil—Nausea—Lovastatin—atherosclerosis	0.00455	0.00455	CcSEcCtD
Ceftaroline fosamil—Rash—Simvastatin—atherosclerosis	0.00451	0.00451	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Simvastatin—atherosclerosis	0.00451	0.00451	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Niacin—atherosclerosis	0.0045	0.0045	CcSEcCtD
Ceftaroline fosamil—Headache—Simvastatin—atherosclerosis	0.00448	0.00448	CcSEcCtD
Ceftaroline fosamil—Nausea—Ezetimibe—atherosclerosis	0.00446	0.00446	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Pravastatin—atherosclerosis	0.00443	0.00443	CcSEcCtD
Ceftaroline fosamil—Dizziness—Niacin—atherosclerosis	0.00435	0.00435	CcSEcCtD
Ceftaroline fosamil—Dizziness—Pravastatin—atherosclerosis	0.00428	0.00428	CcSEcCtD
Ceftaroline fosamil—Nausea—Simvastatin—atherosclerosis	0.00425	0.00425	CcSEcCtD
Ceftaroline fosamil—Vomiting—Niacin—atherosclerosis	0.00418	0.00418	CcSEcCtD
Ceftaroline fosamil—Rash—Niacin—atherosclerosis	0.00414	0.00414	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Niacin—atherosclerosis	0.00414	0.00414	CcSEcCtD
Ceftaroline fosamil—Headache—Niacin—atherosclerosis	0.00412	0.00412	CcSEcCtD
Ceftaroline fosamil—Vomiting—Pravastatin—atherosclerosis	0.00411	0.00411	CcSEcCtD
Ceftaroline fosamil—Rash—Pravastatin—atherosclerosis	0.00408	0.00408	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Pravastatin—atherosclerosis	0.00408	0.00408	CcSEcCtD
Ceftaroline fosamil—Headache—Pravastatin—atherosclerosis	0.00405	0.00405	CcSEcCtD
Ceftaroline fosamil—Nausea—Niacin—atherosclerosis	0.0039	0.0039	CcSEcCtD
Ceftaroline fosamil—Nausea—Pravastatin—atherosclerosis	0.00384	0.00384	CcSEcCtD
